Drug Maker Will Soon Hold Patent On THC, CBD As Cancer Cures

 In Cancer, Health, Medical Marijuana, National News

GW Pharmaceuticals, a drug company that specializes in cannabis-based pharmaceuticals, has received early approval on a patent covering the use of marijuana chemicals for treating brain cancer.

GW Pharmaceuticals announced Wednesday that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating gliomas.

Once a patent application is deemed a genuine invention, the Patent Office sends a Notice of Allowance that outlines the fees involved with final approval.

Read  more at leafscience.com